High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
2023 · Lung Cancer · 3 citations
https://doi.org/10.1016/j.lungcan.2023.107417
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
389
Citations
9
h-index
8
i10-index
Giulia Apollonio is an academic researcher from Fondazione IRCCS Istituto Nazionale dei Tumori. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 9, co-authored 27 publications.
Click to start Chat